PASSAGE BIO, INC. Accounts Payable
PASSAGE BIO, INC. (PASG) had Accounts Payable of $902.00 thousand as of 2026-06-30, per its S-4/A filed 2026-09-03.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-09-03
- 2026-06-30: Accounts Payable, Current $902.00K.
- 2026-03-31: Accounts Payable, Current $1.31M.
- 2025-12-31: Accounts Payable, Current $1.11M.
- 2025-09-30: Accounts Payable, Current $952.00K.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $902.00K S-4/A · filed 2026-09-03 |
| 2026-03-31 | $1.31M S-4 · filed 2026-07-21 |
| 2025-12-31 | $1.11M S-4/A · filed 2026-09-03 |
| 2025-09-30 | $952.00K 10-Q · filed 2025-11-10 |
| 2025-06-30 | $2.40M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $1.46M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $742.00K S-4/A · filed 2026-09-03 |
| 2024-09-30 | $1.49M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $621.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $1.69M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $1.30M 10-K · filed 2025-03-04 |
| 2023-09-30 | $2.75M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $3.38M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $3.03M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $4.07M 10-K · filed 2024-03-04 |
| 2022-09-30 | $4.51M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $8.21M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $9.13M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $9.45M 10-K · filed 2023-03-06 |
| 2021-09-30 | $8.98M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $16.40M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $6.25M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $5.26M 10-K · filed 2022-03-03 |
| 2020-09-30 | $3.44M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $7.21M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $2.53M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $629.00K 10-K · filed 2021-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |